Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03956654
Title A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer (RibOB)
Acronym RibOB
Recruitment Completed
Gender female
Phase FDA approved
Variant Requirements No
Sponsors Universitaire Ziekenhuizen Leuven
Indications
Therapies
Age Groups: senior
Covered Countries BEL


No variant requirements are available.